You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Melanoma

Showing 1 - 25 of 5,258
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Psychoeducation for Uveal Melanoma

Not yet recruiting
  • Uveal Melanoma
  • Education for Intervention
  • Best Practice
  • (no location specified)
Oct 4, 2023

Melanoma Trial in Beijing (IBI363)

Not yet recruiting
  • Melanoma
  • IBI363
  • Beijing, Beijing, China
    Beijing Cancer Hospital
Oct 7, 2023

Participation Patterns Among Stage IV Melanoma Patients

Not yet recruiting
  • Stage IV Melanoma
    • San Francisco, California
      Power Life Sciences
    Oct 16, 2023

    Tumor Skin, Metastatic Melanoma, Melanoma Trial in Orlando, Louisville (OBX-115)

    Active, not recruiting
    • Tumor Skin
    • +2 more
    • OBX-115
    • Orlando, Florida
    • +1 more
    Sep 28, 2023

    Profiling of Circulating Immune Cells to Uncover Response

    Not yet recruiting
    • Melanoma
      • (no location specified)
      Nov 23, 2023

      Monitoring T Cell Responses in Melanoma, Lung and Other Cancer

      Recruiting
      • Clinical Stage III Cutaneous Melanoma AJCC v8
      • +9 more
      • Biospecimen Collection
      • Electronic Health Record Review
      • Rochester, Minnesota
        Mayo Clinic in Rochester
      Oct 4, 2023

      Melanoma Trial (ABP 206, Nivolumab)

      Not yet recruiting
      • Melanoma
      • (no location specified)
      Sep 20, 2023

      Stage III Malignant Melanoma of Skin AJCC V6, Stage IV Malignant Melanoma of Skin Trial in Santiago (TAPCells vaccine)

      Completed
      • Stage III Malignant Melanoma of Skin AJCC V6
      • Stage IV Malignant Melanoma of Skin
      • TAPCells vaccine
      • Santiago, RM, Chile
        Faculty of Medicine, University of Chile
      Nov 21, 2023

      Metastatic Uveal Melanoma Trial in Tampa (ZIV-Aflibercept, Cemiplimab)

      Recruiting
      • Metastatic Uveal Melanoma
      • Tampa, Florida
        Moffitt Cancer Center
      Nov 2, 2023

      Melanoma Trial (GME751, Keytruda - EU, Keytruda - US)

      Not yet recruiting
      • Melanoma
      • (no location specified)
      Nov 22, 2023

      Phase of Uveal Melanoma: A Prospective Multi-method Study

      Not yet recruiting
      • Uveal Melanoma
      • Questionnaires and interviews
      • (no location specified)
      Oct 4, 2023

      Melanoma Trial (Fluzoparib Camrelizumab Temozolomide)

      Not yet recruiting
      • Melanoma
      • Fluzoparib Camrelizumab Temozolomide
      • (no location specified)
      Aug 9, 2023

      EVALUATING THE CURRENT STANDARD OF CARE FOR PATIENTS DIAGNOSED

      Not yet recruiting
      • Melanoma (Skin)
      • Melanoma
        • (no location specified)
        Jun 2, 2023

        Uveal Melanoma Trial in Pittsburgh (Tebentafusp)

        Not yet recruiting
        • Uveal Melanoma
        • Pittsburgh, Pennsylvania
          UPMC Hillman Cancer Center
        Oct 5, 2023

        Melanoma Trial (Tranexamic acid, Saline)

        Not yet recruiting
        • Melanoma
        • (no location specified)
        Jun 2, 2023

        Uveal Melanoma, Metastatic Cutaneous Melanoma Trial (Autologous Tumor Infiltrating Lymphocytes, Melphalan, Interleukin-2)

        Not yet recruiting
        • Uveal Melanoma
        • Metastatic Cutaneous Melanoma
        • Autologous Tumor Infiltrating Lymphocytes
        • +2 more
        • (no location specified)
        Jun 5, 2023

        Uveal Melanoma Trial in Grand Rapids (Darovasertib)

        Recruiting
        • Uveal Melanoma
        • Grand Rapids, Michigan
          The Cancer and Hematology Centers
        Jun 14, 2023

        PD-1 Refractory Advanced Melanoma Trial in Pittsburgh (Responder-Derived Fecal microbiota transplantation (R-FMT, Pembrolizumab,

        Not yet recruiting
        • PD-1 Refractory Advanced Melanoma
        • Responder-Derived Fecal microbiota transplantation (R-FMT
        • +2 more
        • Pittsburgh, Pennsylvania
          UPMC Hillman Cancer Center
        Sep 1, 2023

        Melanoma Trial in Beijing (tunlametinib, paclitaxel +carboplatin, or temozolomide +cisplatin, or dacarbazine +cisplatin)

        Not yet recruiting
        • Melanoma
        • tunlametinib
        • paclitaxel +carboplatin, or temozolomide +cisplatin, or dacarbazine +cisplatin
        • Beijing, Beijing, China
          Beijing Cancer Hospital
        Aug 15, 2023

        Gut and Tumor Microbiome in Advanced ER-positive and

        Not yet recruiting
        • Breast Cancer
        • Melanoma
        • Observation
        • (no location specified)
        Nov 6, 2023

        Tumor Infiltrating Lymphocytes, Safety, Melanoma Trial in Beijing (GC101 TIL)

        Recruiting
        • Tumor Infiltrating Lymphocytes
        • +4 more
        • GC101 TIL
        • Beijing, China
          Beijing Cancer Hospital
        Nov 7, 2023

        Baseline Metastases on Clinical Outcomes Among BRAF Positive

        Completed
        • BRAF Positive Metastatic Melanoma
          • East Hanover, New Jersey
            Novartis
          Aug 2, 2023

          Melanoma Trial (ABP 206, FDA-licensed Nivolumab, EU-authorized Nivolumab)

          Not yet recruiting
          • Melanoma
          • ABP 206
          • +2 more
          • (no location specified)
          Jun 8, 2023

          Melanoma, Malignant Melanoma Trial (T3011 + Cobimetinib)

          Not yet recruiting
          • Melanoma
          • Malignant Melanoma
          • T3011 + Cobimetinib
          • (no location specified)
          Mar 3, 2023

          Metastatic Uveal Melanoma Trial in Grand Rapids (IDE196, Crizotinib, Pembrolizumab)

          Recruiting
          • Metastatic Uveal Melanoma
          • Grand Rapids, Michigan
            The Cancer and Hematology Centers
          Aug 14, 2023